Midcourse Review  >  Table of Contents  > Focus Area 4: Chronic Kidney Disease  >  Disparities Table

Figure 4-2. Disparities Table for Focus Area 4: Chronic Kidney Disease
Disparities from the best group rate for each characteristic at the most recent data point and changes in disparity from the baseline to the most recent data point.



Characteristics: Gender and Income
Population-based objectives Female Male Poor Near poor Middle/high income Summary index
4-1. End-stage renal disease: new cases (1997, 2002)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix. The group with the best rate for specified characteristic. 10-49 percent difference from the best group rateData not available.Data not available.Data not available.Data not available.
4-2. Cardiovascular disease deaths: persons with chronic kidney failure (1997, 2002)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix. Less than 10 percent difference from the best group rate or not statistically significantThe group with the best rate for specified characteristic. Data not available.Data not available.Data not available.Data not available.
4-3. Counseling: chronic kidney failure care
patients (1996)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix.
The group with the best rate for specified characteristic. The group with the best rate for specified characteristic. Data not available.Data not available.Data not available.Data not available.
4-4. Use of arteriovenous fistulas: hemodialysis patients 20+ years (1997, 2001)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix. 10-49 percent difference from the best group rateThe group with the best rate for specified characteristic. Data not available.Data not available.Data not available.Data not available.
4-5. Registration for kidney transplantation:
kidney patients 20+ years (1998, 2002)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.
Less than 10 percent difference from the best group rate or not statistically significantThe group with the best rate for specified characteristic. Data not available.Data not available.Data not available.Data not available.
4-6. Waiting time for kidney transplantation:
kidney patients < 70 years (1992-94, 1999)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix.
Less than 10 percent difference from the best group rate or not statistically significantThe group with the best rate for specified characteristic. Data not available.Data not available.Data not available.Data not available.
4-7. End-stage renal disease due to diabetes
(1997, 2002)The variability of best group rates was assessed, and disparities of ≥10% are statistically significant at the 0.05 level. Changes in disparity over time, noted with arrows, are statistically significant at the 0.05 level. See Technical Appendix.
The group with the best rate for specified characteristic. Increase in disparity 10-49 percentage points (10-49 percent difference from the best group rate). Data not available.Data not available.Data not available.Data not available.
4-8a. Medical evaluation of persons with type 1 or 2 diabetes and chronic kidney disease (2000)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix. The group with the best rate for specified characteristic. The group with the best rate for specified characteristic. Data not available.Data not available.Data not available.Data not available.
4-8b. Medical treatment of persons with type 1 or 2
diabetes and chronic kidney disease (2000)Measures of variability were not available. Thus, the variability of best group rates was not assessed, and the statistical significance of disparities and changes in disparity over time could not be tested. See Technical Appendix.
Data not available.Data not available.Data not available.Data not available.Data not available.Data not available.

Notes:

Years in parentheses represent the baseline data year and the most recent data year (if available).

Disparity from the best group rate is defined as the percent difference between the best group rate and each of the other group rates for a characteristic (for example, race and ethnicity). The summary index is the average of these percent differences for a characteristic. Change in disparity is estimated by subtracting the disparity at baseline from the disparity at the most recent data point. Change in the summary index is estimated by subtracting the summary index at baseline from the summary index at the most recent data point. See Technical Appendix for more information.







<<  Previous—Disparities Table: Race and Ethnicity   |   Table of Contents   |   Next—Objectives and Subobjectives  >>


[ Top ]